EGF Theramed Health Corp. engages in the development of psychedelic drugs for the treatment of mental health. It offers psychedelics for the treatment of conditions, such as treatment-resistant depression, anxiety, PTSD, and depression, as well as natural health and wellness products. The company is headquartered in Vancouver, Canada.
Stock data | 2023 | Change |
---|---|---|
Shares Outstanding | 9.99M | 363.47% |
Employees | 0 | N/A |
Shareholder Equity | -2.48M | 6.14% |
Earnings | 2023 | Change |
---|---|---|
EPS | -0.06 | N/A |